In contrast, a clinical assay with 172 patients with active RA showed that UC-MSC administration is safe and that the improvement in patients is accompanied by an increase of CD4+CD25+Foxp3+ Tregs in peripheral blood and a decrease of TNFα secretion [166]. The gene discussed is TNF; the disease is rheumatoid arthritis.